Drug Side Effects
Search
MYELOID METAPLASIA
MYELOID METAPLASIA
was reported 20 times
MYELOID METAPLASIA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Catechol-O-Methyltransferase Inhibitor [EPC]
1
0.0002
1
Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
1
0.0001
2
Nonergot Dopamine Agonist [EPC]
1
0.0001
3
Typical Antipsychotic [EPC]
1
0.0000
4
Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
1
0.0000
5
Phenothiazine [EPC]
1
0.0000
6
Central alpha-2 Adrenergic Agonist [EPC]
1
0.0000
7
Aromatic Amino Acid [EPC]
1
0.0000
8
Topoisomerase Inhibitor [EPC]
1
0.0000
9
Interleukin-12 Antagonist [EPC]
1
0.0000
10
Interleukin-23 Antagonist [EPC]
1
0.0000
11
Parathyroid Hormone Analog [EPC]
1
0.0000
12
Alkylating Drug [EPC]
2
0.0000
13
Sulfonylurea [EPC]
1
0.0000
14
Selective T Cell Costimulation Modulator [EPC]
1
0.0000
15
Janus Kinase Inhibitor [EPC]
1
0.0000
16
Interferon beta [EPC]
1
0.0000
17
Expectorant [EPC]
1
0.0000
18
Thiazide Diuretic [EPC]
1
0.0000
19
Folate Analog Metabolic Inhibitor [EPC]
2
0.0000
20
Platinum-based Drug [EPC]
1
0.0000
21
Dihydropyridine Calcium Channel Blocker [EPC]
1
0.0000
22
Corticosteroid [EPC]
3
0.0000
23
Thalidomide Analog [EPC]
1
0.0000
24
Kinase Inhibitor [EPC]
1
0.0000
25
Proton Pump Inhibitor [EPC]
1
0.0000